CASP3 and neoplasm: In cisplatin-resistant A2780-CisR bearing tumor, there was significant reduction in OSMR and Ki67 levels and increase in Cleaved caspase 3 levels when treated with B21 and cisplatin in combination (Fig. 5g, h).